The ROE as of December 2024 (TTM) for Clene Inc. (CLNN) is -1106.30%

According to Clene Inc.’s latest financial reports and current stock price. The company's current ROE is -1106.30%. This represents a change of -467.54% compared to the average of 301.00% of the last 4 quarters.

Clene Inc. (CLNN) Historical ROE (quarterly & annually)

How has CLNN ROE performed in the past?

The mean historical ROE of Clene Inc. over the last ten years is -936.24%. The current -1106.30% ROE has changed 18.16% with respect to the historical average. Over the past ten years (40 quarters), CLNN's ROE was at its highest in in the June 2024 quarter at 1.35%. The ROE was at its lowest in in the March 2022 quarter at -698.17%.

Clene Inc. (CLNN) ROE by Quarter and Year

Discovering the peaks and valleys of Clene Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clene Inc. (CLNN) Average ROE

How has CLNN ROE performed in the past?

The current ROE of Clene Inc. (CLNN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Clene Inc. (CLNN) ROE vs. Peers

How is CLNN’s ROE compared to its peers?

Clene Inc.’s ROE is less than MediciNova, Inc. (0%), greater than Eliem Therapeutics, Inc. (-20.70%), less than Molecular Partners AG (0%), greater than Champions Oncology, Inc. (-39.16%), less than Cyteir Therapeutics, Inc. (66.22%), less than Century Therapeutics, Inc. (-9.44%), greater than Kezar Life Sciences, Inc. (-66.58%), greater than Mineralys Therapeutics, Inc. (-59.73%), greater than Nkarta, Inc. (-55.92%), greater than NGM Biopharmaceuticals, Inc. (-27.13%), greater than Ikena Oncology, Inc. (-55.66%), greater than Foghorn Therapeutics Inc. (-39.59%), less than Werewolf Therapeutics, Inc. (167.93%), greater than Immunome, Inc. (-58.83%), greater than Sensei Biotherapeutics, Inc. (-139.72%), greater than NextCure, Inc. (-53.86%), greater than Nuvation Bio Inc. (-62.50%), greater than Graphite Bio, Inc. (-108.68%), greater than Merrimack Pharmaceuticals, Inc. (-57.96%), greater than null (-35.28%),

Build a custom stock screener for Clene Inc. (CLNN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clene Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clene Inc. (CLNN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clene Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.